Recruiting

Observational Study

Sponsor:

Indiana University

Code:

NCT03616483

Conditions

Plasma Cell Dyscrasias

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

This is a non-interventional trial

Study Details

Brief summary:

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Conditions

Plasma Cell Dyscrasias

Study ID

NCT03616483

Start date

Jun 18, 2018

Status verified date

Oct, 2025

Completion date

Jun 30, 2028

Anticipated

Primary completion date

Jun 30, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Male or female patients ≥ 18 years of age at the time of informed consent
2. Has been diagnosed with or is suspected to have one of the following:

1. Monoclonal Gammopathy of Undetermined Significance (MGUS)
2. Smoldering Multiple Myeloma
3. Multiple Myeloma
4. Bony or Soft Tissue Plasmacytoma
5. Primary Amyloidosis

Exclusion Criteria:

< 18 years of age

Have not been diagnosed with one of the following:

Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Study Design

Enrollment

2500 participants

Anticipated

Interventions and Outcome Measures

Interventions

This is a non-interventional trial

This is a non-interventional trial

Primary outcome measure

  • Create a repository [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Attaya Suvannasankha, MD

317-274-0843asuvanna@iu.edu

Nisha George, MD

(317) 274-6635nishgeor@iu.edu

Locations

Indiana University Simon Cancer Center

Recruiting

Indianapolis, Indiana, United States, 46202

Contacts

Attaya Suvannasankha, MD

317-274-0843asuvanna@iu.edu

Nisha George, MD

(317) 274-6635nishgeor@iu.edu

More Information

Sponsor

Indiana University

Last update posted

Nov 10, 2025

Last verified

Oct, 2025

Keywords

  • Multiple myeloma
  • Monoclonal gammopathy of undetermined significance
  • Plasmacytoma
  • Smoldering multiple myeloma

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Indiana University on 2025-11-10.